Argenx
ARGX
#456
Rank
โ‚ฌ43.81 B
Marketcap
708,04ย โ‚ฌ
Share price
-0.85%
Change (1 day)
10.34%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ43.81 Billion

As of February 2026 Argenx has a market cap of โ‚ฌ43.81 Billion. This makes Argenx the world's 456th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ43.81 B-2.18%
2025โ‚ฌ44.79 B24.46%
2024โ‚ฌ35.98 B76.3%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Argenx was reported to be:

โ‚ฌ43.18 Billion
by Nasdaq info icon info icon
โ‚ฌ43.81 Billion
by CompaniesMarketCap info icon info icon